PPAR Agonists in Primary Biliary Cholangitis
Bernd Schnabl
Abstract
This editorial describes the science behind clinical trials testing elafibranor and seladelpar in the treatment of primary biliary cholangitis.
Topics & Concepts
MedicineInternal medicineGastroenterologyPrimary (astronomy)Ursodeoxycholic acidPrimary sclerosing cholangitisPhysicsDiseaseAstronomyLiver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsLiver Disease Diagnosis and Treatment